Form 4 for PRME Prime Medicine, Inc.

Accepted 2022-10-26 00:00:00 ET · period of report 2022-10-24 · accession 0001628280-22-027123 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-10-26	2022-10-24	PRME	Liu David R.	10%	C - Cnv Deriv	—	+321.7K	21.16M	+2%	—
D	2022-10-26	2022-10-24	PRME	Liu David R.	10%	C - Cnv Deriv	$0.00	-1.00M	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-10-24	C	A	321,665	—	21,156,945	D	—	—	(F1) The shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") were convertible into Common Stock on a one-for-3.10880 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on October 24, 2022. The Series A Preferred Stock had no expiration date.
2	Derivative	Series A Convertible Preferred Stock	2022-10-24	C	D	1,000,001	$0.00	0	D	— · — to —	321,665 Common Stock	(F1) The shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") were convertible into Common Stock on a one-for-3.10880 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on October 24, 2022. The Series A Preferred Stock had no expiration date.